Nanologica AB (publ) Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Andreas Bhagwani, was filed 21 Apr 2026.
Nanologica AB (publ): what insiders have been doing
Nanologica AB (publ) is a Health Care company. Its directors and officers file their transactions with Finansinspektionen. Between 4 November 2025 and 4 November 2026, 3 insiders published 7 filings.
Not one open-market sale was filed. On the buying side, 1 insider reported 3 purchases totalling €556k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Andreas Bhagwani filed the largest purchase, €281k, on 13 March 2026. Among those who bought: 1 chief executive.
The clock since the last published purchase (21 April 2026) now reads 201 days. The median gap between a trade and its publication by Finansinspektionen is 3 days. The regulation allows three business days to notify a trade (MAR article 19).
With 7 filings in twelve months, the company is quieter than the median of 9 filings across the 1,032 companies we follow on the same exchange. Looking back to 2017, when coverage begins, insiders filed 34 purchases and 12 sales.
In the same sector, recent insider purchases at Dynavox Group AB and UCB also feature in our signals. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Who traded when
BuySaleTransparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 21,453,780 shares0AktieISIN SE0005454873FI:csv-27c0d8fd58d920a78407
- 2,600,000 shares@ SEK 0.400.72% mcap100.0% of flowAktieISIN SE0005454873FI:A003X713-1Canonical exit: 19 Jul 2026 (T+90)
- 89,872,048 shares@ SEK 0.40BTA (betald tecknad aktie)ISIN SE0028001016FI:csv-bb36eadfbc2b12da3135
- 38,516,592 shares0Teckningsrätt/UniträttISIN SE0028001008FI:A003X483-1
- 4,900,000 shares@ SEK 0.4017.2% of flowAktieISIN SE0005454873FI:csv-ed7cd9cdc47774da1bcdCanonical exit: 28 Jun 2026 (T+90)
- 21,453,780 shares@ SEK 0.405.98% mcap100.0% of flowAktieISIN SE0005454873FI:A003X186-1
- 7,500,000 shares@ SEK 0.4026.9% of flowAktieISIN SE0005454873FI:csv-3f2b0feea36997119b31Canonical exit: 10 Jun 2026 (T+90)
- 293,815 shares@ SEK 1.000.19% mcap100.0% of flowAktieISIN SE0005454873FI:A003Q717-1Canonical exit: 14 Oct 2025 (T+90)
- 666,570 shares@ SEK 0.991969.9% of flowAktieISIN SE0005454873FI:csv-32b02488c13cae4423e7Canonical exit: 24 Jul 2025 (T+90)
- 5,755,020 shares@ SEK 2.2528.1% of flowAktieISIN SE0005454873FI:csv-c82728f916a2c013e2f0
- 1,438,755 shares0TeckningsoptionISIN SE0023111836FI:csv-527975731cb7dab6922d
- 14,503,076 shares0Teckningsrätt/UniträttISIN SE0023111844FI:csv-27b9255a71f43f3a623a
- 14,503,076 shares@ SEK 2.2571.9% of flowBTU (betald tecknad unit)ISIN SE0023111851FI:csv-25c7eb11e95857752f58
- 32,073 shares@ SEK 9.00BTU (betald tecknad unit)ISIN SE0023111851FI:csv-f6446d0f6212178c251e
- 72,507 shares@ SEK 2.2551.2% of flowTeckningsrätt/UniträttISIN SE0005454873FI:csv-d2cc83ad8b462b52b59e
- 69,008 shares@ SEK 2.25100.0% of flowTeckningsrätt/UniträttISIN SE0005454873FI:csv-c33e767264f9ddb863e5
- 48,300 shares@ SEK 2.25100.0% of flowTeckningsrätt/UniträttISIN SE0005454873FI:csv-2e1762b444b81bcee674
- 351,631 shares@ SEK 2.25100.0% of flowTeckningsrätt/UniträttISIN SE0005454873FI:csv-4b4de35cde3b6cd6bf17
- 37,000 shares@ SEK 2.25100.0% of flowTeckningsrätt/UniträttISIN SE0005454873FI:csv-41d7f72d91ed645233a1
- 917,641 shares@ SEK 2.25100.0% of flowTeckningsrätt/UniträttISIN SE0005454873FI:csv-7f015a16b33a0857814a
- 69,008 shares@ SEK 2.2548.8% of flowTeckningsrätt/UniträttISIN SE0005454873FI:csv-d6dbda41792e5f4ab027
- 39,838 shares@ SEK 9.00BTU (betald tecknad unit)ISIN SE0023111851FI:csv-cb4c9bf674128a0bc948
- 447,628 shares@ SEK 2.2510.9% of flowTeckningsrätt/UniträttISIN SE0005454873FI:csv-ecabb4c70a6b36a8600b
- 69,008 shares@ SEK 2.251.7% of flowTeckningsrätt/UniträttISIN SE0005454873FI:csv-3e6fb3939c5c3a3f471f
- 48,300 shares@ SEK 2.251.2% of flowTeckningsrätt/UniträttISIN SE0005454873FI:csv-e11f0366d4adbeb46fc1
25 of 87 declarations
About Nanologica AB (publ)
Nanologica AB (publ) is a Swedish company focused on developing innovative solutions for drug delivery. It is listed on the XSTO market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
